Press Releases - G1 Therapeutics, Inc.

Press Releases

Date	Title
5/13/20	G1 Therapeutics to Present Data Showing Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer at the ASCO20 Virtual Scientific Program
5/6/20	G1 Therapeutics Provides First Quarter 2020 Corporate and Financial Update
4/29/20	G1 Therapeutics to Provide First Quarter 2020 Corporate and Financial Update on May 6, 2020
4/7/20	G1 Therapeutics to Present at 19th Annual Needham Virtual Healthcare Conference on April 14, 2020
3/12/20	G1 Therapeutics Announces Appointment of New Board Member and Chief Commercial Officer
2/26/20	G1 Therapeutics Provides Fourth Quarter and Full-Year 2019 Corporate and Financial Update
2/24/20	G1 Therapeutics to Present at Investor Conferences in March 2020
2/19/20	G1 Therapeutics to Provide Fourth Quarter and Full Year 2019 Corporate and Financial Update on February 26, 2020
2/17/20	G1 Therapeutics to Participate in BTIG Targeted Therapeutics Conference on February 24, 2020
2/6/20	G1 Therapeutics to Participate in Guggenheim Health Talks: Oncology Day on February 13, 2020